Clinical and immunologic characteristics of melanoma-associated retinopathy syndrome: eleven new cases and a review of 51 previously published cases.
about
Paraneoplastic neurological syndromesAutoantibodies against retinal proteins in paraneoplastic and autoimmune retinopathyParaneoplastic vitelliform retinopathy: clinicopathologic correlation and review of the literatureAutoimmune retinopathy.SEREX identification of new tumor antigens linked to melanoma-associated retinopathy.Diagnosis of occult melanoma using transient receptor potential melastatin 1 (TRPM1) autoantibody testing: a novel approach.A review of current indications, adverse effects, and administration recommendations for intravenous immunoglobulin.Melanoma-associated retinopathy: a paraneoplastic autoimmune complicationAutoantibodies in Melanoma-Associated Retinopathy Recognize an Epitope Conserved Between TRPM1 and TRPM3.Anti-γ-enolase autoimmune retinopathy manifesting in early childhood.Efficacy of rituximab in non-paraneoplastic autoimmune retinopathy.Two mouse models for recoverin-associated autoimmune retinopathy.Autoantibody against transient receptor potential M1 cation channels of retinal ON bipolar cells in paraneoplastic vitelliform retinopathy.Autoantibodies in melanoma-associated retinopathy target TRPM1 cation channels of retinal ON bipolar cellsSerum TRPM1 autoantibodies from melanoma associated retinopathy patients enter retinal on-bipolar cells and attenuate the electroretinogram in miceDegeneration of retinal on bipolar cells induced by serum including autoantibody against TRPM1 in mouse model of paraneoplastic retinopathyNeurologic paraneoplastic syndromes.Retinitis pigmentosa: understanding the clinical presentation, mechanisms and treatment options.Cancer-induced, immune-mediated ocular degenerations.Central and paracentral visual field defects and driving abilities.Immunotherapy for paraneoplastic neurological disorders.TRP channel gene expression in the mouse retina.Recoverin as a cancer-retina antigen.Clinical disorders affecting mesopic vision.Paraneoplastic syndromes in patients with primary head and neck cancer.Spontaneous improvement of rod system function in a patient with melanoma-associated retinopathy.The enigma of autoimmune retinopathy.Autoantibody targets and their cancer relationship in the pathogenicity of paraneoplastic retinopathyCancer-associated retinopathy in patients with breast carcinoma.Negative electroretinograms in the pediatric and adult population.Non-Paraneoplastic Autoimmune Retinopathy: The First Case Report in Korea.Sudden acquired retinal degeneration syndrome (SARDS) - a review and proposed strategies toward a better understanding of pathogenesis, early diagnosis, and therapy.Mimics and chameleons of optic neuritis.Cancer-retina antigens as potential paraneoplastic antigens in melanoma-associated retinopathy.Choroidal atrophy in a patient with paraneoplastic retinopathy and anti-TRPM1 antibodyExudative Polymorphous Vitelliform Retinopathy: Importance of Early Recognition of the Condition in Patients with Metastatic Melanoma.Introducing MARCo: Histoserological Findings of a Multi-Organic Paraneoplastic Syndrome in Cutaneous Melanoma Patients.Delayed presentation of melanoma-associated retinopathy and subsequent resolution with cytoreduction surgery.Melanoma-associated retinopathy: high frequency of subclinical findings in patients with melanoma.A negative electroretinogram (ERG) in a case of probable multiple system atrophy (MSA).
P2860
Q21093169-43CBA423-830C-41FB-A57F-9C1EAB184C66Q24800667-7E0F4263-E7E2-434C-8FEC-C0A9C7B251E3Q26865239-DC6C399A-603D-413D-80B1-AD3769847068Q27694736-7F61DD61-12E4-46AC-96DE-4C113158C745Q31124144-FFC916A4-9C54-41C8-9EEF-3BDF05EE0E2DQ31139864-56E187FA-11B1-4592-97F3-29642605F2D9Q33399594-10397AB2-4BDA-49FD-B03F-68C12C77C652Q33518323-535DAB47-0986-4F12-967D-B5A70F7545BAQ33756020-C15D0619-4A6C-48A1-8957-D7AB9F3C62E5Q33768436-93E3BD67-55FD-485A-B8CB-1442966DF91EQ33909097-3881F26F-D7E7-4CB2-9935-651865AB91F3Q34211883-E414F52E-117D-4EA1-BC43-9A9DD1A5FC08Q34475813-EAF285A4-A6BE-46E4-B600-18F6E60CF933Q34778261-C24E7FCD-081C-4123-A5FF-F03EEBAB2B90Q34924436-31199671-5F96-45A2-9BA8-DEE7CD9D3ADCQ35055336-5192648E-4287-4B81-9261-2EA7CD931383Q35603875-1E411115-11F0-41D3-9A9D-79E3C1AF034EQ35709922-546F7B7B-4952-4AA3-822C-1C2B0BDCF0ABQ36194825-093154E4-E313-437B-A283-9B97A7147EECQ36222758-09872E9C-AB6A-4AF3-AE53-B7095FAAD530Q36273401-7F537B5C-6398-4114-8143-D58DE1346C62Q36280955-663F8B55-DB0B-4C3A-A0EC-F233829D15CEQ36380906-535034C7-C1C3-4D91-9834-28DBD19754D9Q36473176-A042CE4C-4A7B-481A-8C5B-524220758151Q36700560-260BEC1A-2BFC-494B-A4BF-1C2EAE0F7C82Q36948854-ADA28E02-A450-4E11-B917-6F8EF2C5CE12Q37088449-831011C6-CE5D-4BEB-B4B5-317940CFF3FCQ37188746-8CAAA78B-62E5-4C9C-966B-34B36A92FC98Q37397770-0C57A1EB-2630-4F9B-94B8-346550022CB4Q37975929-8D94A707-E15D-48DF-8181-939FC5BED76DQ38256331-141E4438-7E4F-42D1-80DA-AB1213BFF16AQ38533795-24BD561C-1ED4-400A-964A-776F63E4DE98Q38695978-ED54BFF9-4A55-4FE1-91A7-4D34FAD880CEQ39936295-B50D66A9-35B4-4267-92E6-EA712581669EQ41860529-C6CCA571-A317-4637-B6DB-5865B60B122DQ42049392-55DD7E8B-1292-4208-B5E9-FE476903ACF0Q42364290-31C3940A-701A-43F5-9DA6-BEAB72476BC4Q43663422-968E420A-3162-4263-8495-619F36790E7CQ44531967-EA46241B-4FC1-46D0-A4BC-0744A0B6961EQ46235065-D8CD3AAC-FA4D-4A40-AC66-1D88CA5BFCF8
P2860
Clinical and immunologic characteristics of melanoma-associated retinopathy syndrome: eleven new cases and a review of 51 previously published cases.
description
2001 nî lūn-bûn
@nan
2001 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Clinical and immunologic chara ...... 51 previously published cases.
@ast
Clinical and immunologic chara ...... 51 previously published cases.
@en
Clinical and immunologic chara ...... 51 previously published cases.
@nl
type
label
Clinical and immunologic chara ...... 51 previously published cases.
@ast
Clinical and immunologic chara ...... 51 previously published cases.
@en
Clinical and immunologic chara ...... 51 previously published cases.
@nl
prefLabel
Clinical and immunologic chara ...... 51 previously published cases.
@ast
Clinical and immunologic chara ...... 51 previously published cases.
@en
Clinical and immunologic chara ...... 51 previously published cases.
@nl
P2093
P1476
Clinical and immunologic chara ...... 51 previously published cases.
@en
P2093
P304
P356
10.1097/00041327-200109000-00004
P577
2001-09-01T00:00:00Z